Natus Medical reported $8.54M in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abiomed ABMD:US $ 60.44M 109.72M
Accuray ARAY:US $ 2.41M 8.22M
Atricure ATRC:US $ 98.67M 113.75M
Boston Scientific BSX:US $ 387M 125M
Cardiovascular Systems CSII:US $ -8.12M 3.21M
Cooper Companies COO:US $ 128.6M 28M
General Electric GE:US $ 570M 1563M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Globus Medical GMED:US $ 53.33M 7.45M
Hill Rom HRC:US $ 114.1M 34.5M
Inogen INGN:US $ 6.37M 5.3M
Insulet PODD:US $ 32.2M 46M
Integra Lifesciences IART:US $ 57.76M 5.42M
Koninklijke Philips PHG:US 358M 273M
Masimo MASI:US $ 67.61M 2.48M
Medtronic MDT:US $ 1563M 704M
Mesa Laboratories MLAB:US $ 4.2M 1.08M
Natus Medical BABY:US $ 8.54M 2.53M
Orthofix International OFIX:US $ -0.31M 4.58M
Perkinelmer PKI:US $ 221.97M 110.52M
Philips PHIA:NA € 358M 273M
Surmodics SRDX:US $ -0.49M 1.9M
Tandem Diabetes Care TNDM:US $ 7.72M 2.29M
Thermo Fisher Scientific TMO:US $ 2278M 115M
Trinity Biotech TRIB:US $ 2.75M 2.53M